-
Stocks in Focus: MGM Resorts International (NYSE:MGM), ArQule Inc. (NASDAQ:ARQL), CSX Corp. (NYSE:CSX), Signal Genetics (NASDAQ:SGNL), Pacific Continental Corp. (NASDAQ:PCBK)
MGM Resorts International (NYSE:MGM)’s 767 page environmental impact study of the MGM Springfield project has cleared the Massachusetts Environmental Policy Act with approval from Secretary of Energy and Environmental Affairs. MGM Resorts International (NYSE:MGM) in last trading activity decreased -3.82% to close at $19.66. Company weekly performance is -8.47% while its quarterly performance stands at…
-
Stocks on the move: ArQule Inc. (NASDAQ:ARQL), Facebook Inc (NASDAQ:FB), Delcath Systems (NASDAQ:DCTH), Nordson Corporation (NASDAQ:NDSN), General Growth Properties, Inc (NYSE:GGP)
ArQule Inc. (NASDAQ:ARQL) announced that it has granted exclusive rights to privately-held pharmaceutical company Angelini Pharma to commercialize Iclusig in Central and Eastern Europe for the indications approved by the European Medicine Agency (EMA). ArQule Inc. (NASDAQ:ARQL) in last trading activity moved up 7.02% to close at $1.22. Company weekly performance is 7.02% while its…
-
Why Trader’s Are Watching: ArQule Inc. (NASDAQ:ARQL), Radius Health (NASDAQ:RDUS), Magna International Inc. (NYSE:MGA), Extreme Networks (NASDAQ:EXTR), Alpha Pro Tech (NYSEMKT:APT)
Arqule Inc (NASDAQ:ARQL) recorded a 1.71% change in the short interest in the past month. The 3-month %change in short interest stands at 14.67%. A decrease in 1-month short interest eases the pressure off the stock while an increase is a negative overhang. The monthly shorted shares now measure at 0.161 times the total shares…
-
Stocks Gaining Momentum: Adamas Pharmaceuticals (NASDAQ:ADMS), ArQule Inc. (NASDAQ:ARQL), MYOS Corporation (NASDAQ:MYOS), Pointer Telocation (NASDAQ:PNTR), Google Inc (NASDAQ:GOOG)
The FDA on Wednesday approved a New Drug Application for Adamas Pharmaceuticals Inc. (NASDAQ:ADMS)’s ADMS 9.9% Namzaric for the treatment of moderate to severe dementia of the Alzheimer’s type. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) in last trading activity moved up 9.90% to close at $16.10. Company weekly performance is 10.05% while its quarterly performance stands at…
-
Biotech Bearish Stocks: Gilead Sciences Inc. (NASDAQ:GILD), VIVUS Inc. (NASDAQ:VVUS), ArQule Inc. (NASDAQ:ARQL), Medivation (NASDAQ:MDVN), La Jolla Pharmaceutical Co. (NASDAQ:LJPC)
Gilead Sciences, Inc. (NASDAQ: GILD) should be concerned about Achillion Pharmaceuticals, Inc.’s (NASDAQ:ACHN) experimental hepatitis C drug trial, the results of which are due to be released later this month. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity fell -14.34% to close at $92.90. Company weekly performance is -9.95% while its quarterly performance stands at…
-
Top Stocks: Goldcorp Inc. (NYSE:GG), ArQule Inc. (NASDAQ:ARQL), Fortress Investment Group LLC (NYSE:FIG), The Dixie Group (NASDAQ:DXYN), Citigroup Inc. (NYSE:C)
Shares of Goldcorp Inc. (NYSE:GG) fell trading Monday as gold prices declined. Goldcorp Inc. (NYSE:GG) in last trading activity decreased -4.98% to close at $17.37. Company weekly performance is -0.29% while its quarterly performance stands at -25.86%. Goldcorp Inc. (NYSE:GG) is -40.78% away from its 52 week high. ArQule Inc. (NASDAQ:ARQL) was upgraded by Zacks…
-
Investors Are Eying On: Yahoo! Inc. (NASDAQ:YHOO), Comcast Corporation (NASDAQ:CMCSA), Flextronics International (NASDAQ:FLEX), Tiger Media (NYSEMKT:IDI), ArQule Inc. (NASDAQ:ARQL)
Yahoo! Inc. (NASDAQ:YHOO) CEO Marissa A. Mayer sold 36,000 shares of the company’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $51.79, for a total value of $1,864,440.00. Yahoo! Inc. (NASDAQ:YHOO) in last trading activity increased 1.15% to close at $50.99. Company weekly performance is -1.45%…
-
Microcap Gainers: Digital Ally Inc. (NASDAQ:DGLY), Pacific Sunwear of California Inc. (NASDAQ:PSUN), Venaxis (NASDAQ:APPY), ArQule Inc. (NASDAQ:ARQL), Sigma Designs (NASDAQ:SIGM)
Digital Ally (NASDAQ:DGLY) Director Elliot M. Kaplan unloaded 5,000 shares of Digital Ally stock on the open market in a transaction dated Monday, November 24th. The stock was sold at an average price of $12.60, for a total transaction of $63,000.00. Following the transaction, the director now directly owns 40,561 shares of the company’s stock,…
-
Biotech Bullish Movers: Array BioPharma (NASDAQ:ARRY), CTI BioPharma Corp. (NASDAQ:CTIC), ArQule Inc. (NASDAQ:ARQL), Radius Health (NASDAQ:RDUS), TrovaGene (NASDAQ:TROV)
Array BioPharma Inc. (NASDAQ:ARRY) announced that it has reached a definitive agreement with Novartis International Pharmaceutical Ltd. to regain full worldwide rights to binimetinib, a MEK inhibitor in three Phase 3 trials. This agreement is conditional on the closing of transactions announced by Novartis and GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected…
-
Investors Alert: Halcon Resources (NYSE:HK), Vince Holding Corp (NYSE:VNCE), Fate Therapeutics (NASDAQ:FATE), ArQule Inc. (NASDAQ:ARQL), Denny’s Corporation (NASDAQ:DENN)
Halcon Resources Corp (NYSE:HK) COO Charles E. Cusack III acquired 40,000 shares of the stock on the open market in a transaction dated Friday, November 28th. The shares were purchased at an average cost of $2.46 per share, for a total transaction of $98,400.00. Following the completion of the transaction, the chief operating officer now…